Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Am J Drug Alcohol Abuse. 2016 Jul 19;42(5):614–620. doi: 10.1080/00952990.2016.1197231

Table 2.

Craving, Depression, Anxiety, and Anhedonia

Number of patients NI+OP 102 96 83 76 54
PI+ON 102 65 46 32 16
PI+OP 102 50 32 28 11
RATING SCALES Medication groups Psychometric data (by weeks of medication)
0 4 8 12 24
Craving for opiates
M±SEM
NI+OP 3.05±0.28 1.09±0.20* 1.01±0.19* 0.70±0.17* 0.33±0.19* Mixed ANOVA
Main Time effect
F4.750=44.71; P=<. 01
PI+ON 3.30±0.28 1.25±0.28* 0.50±0.13* 1.07±0.37* 0.29±0.11*
PI+OP 3.18±0.28 1.15±0.25* 0.70±0.21* 0.53±0.20* 1.09±0.84*
Beck depression scale
M±SEM
NI+OP 18.76±0.91 8.91±0.72* 7.03±0.80* 5.28±0.73* 2.80±0.49* Mixed ANOVA
Main Time effect
F4.750=161.80; P=<. 01
PI+ON 19.92±0.80 9.62±1.06* 6.45±1.16* 7.62±1.45* 6.11±2.03*
PI+OP 20.76±0.83 8.50±1.05* 6.32±1.33* 5.00±1.17* 1.50±0.73*
Spielberger state anxiety scale
M±SEM
NI+OP 46.4±1.06 40.9±1.45* 38.7±1.32* 36.1±1.17* 34.4±1.34* Mixed ANOVA
Main Time effect
F4.750=30.82; P=<. 01
PI+ON 47.0±0.90 42.2±1.61* 39.7±1.64* 40.6±1.87* 38.8±2.14*
PI+OP 48.6±1.00 40.9±1.64* 36.5±1.74* 38.6±1.91* 36.6±3.82*
Spielberger trait anxiety scale
M±SEM
NI+OP 48.0±0.99 43.1±1.03* 40.1±0.94* 39.4±0.89* 37.7±0.93* Mixed ANOVA
Main Time effect
F4.750=31.88; P=<. 01
PI+ON 48.2±0.91 44.3±1.46* 38.6±1.30* 41.4±1.52* 40.3±1.47*
PI+OP 48.5±0.87 41.5±1.27* 41.3±1.79* 39.0±1.73* 39.2±2.27*
Lack of Pleasure (Ferguson Anhedonia Scale)
M±SEM
Me (min-max)
NI+OP 1.00±0.10
1 (0-4)
0.60±0.10
0 (0-3) +
0.23±0.47
0 (0-1) +
0.13±0.05
0 (0-2) +
0.07±0.45
0 (0-2) +
Fridman Test
P=<. 01
PI+ON 1.12±0.10
1 (0-4)
0.67±0.14
0 (0-3) +
0.35±0.10
0 (0-2) +
0.28±0.10
0 (0-2) +
0.06±0.56
0 (0-2) +
Fridman Test
P=<. 01
PI+OP 1.20±0.10
1 (0-4)
0.48±0.11
0 (0-4) +
0.19±0.86
0 (0-2) +
0.17±0.08
0 (0-1) +
0
0 (0-0) +
Fridman Test P=<. 01
Lack of Interest (Ferguson Anhedonia Scale)
M±SEM
Me (min-max)
NI+OP 1.15±0.96
1 (0-4)
0.56±0.10
0 (0-3) +
0.33±0.59
0 (0-2) +
0.20±0.59
0 (0-2) +
0.06±0.41
0 (0-2) +
Fridman Test
P=0.06
PI+ON 1.24±0.10
1 (0-4)
0.70±0.13
0 (0-4) +
0.41±0.96
0 (0-3) +
0.33±0.98
0 (0-2) +
0.06±0.56
0 (0-1) +
Fridman Test
P=0.04
PI+OP 1.43±0.117
1 (0-4)
0.39±0.081
0 (0-3) +
0.23±0.089
0 (0-2) +
0.26±0.113
0 (0-2) +
0
0 (0-0) +
Fridman Test
P=<. 0001
Physical Anhedonia (Chapman scale)
M±SEM
NI+OP 28.9±1.39 26.3±1.51* 26.7±1.66* Mixed ANOVA
Main Time effect
F2.210=30.13; P=<. 01
PI+ON 27.7±1.34 21.8±2.13* 19.6±1.96*
PI+OP 26.4±1.26 23.3±2.92* 14.6±2.96*
Social Anhedonia (Chapman scale)
M±SEM
NI+OP 20.4±0.90 18.4±0.96* 18.6±1.15* Mixed ANOVA
Main Time effect
F2.210=14.03; P=<. 01
PI+ON 19.4±0.95 17.2±1.63* 15.8±2.93*
PI+OP 18.1±0.86 16.1±1.79* 14.3±2.44*

Notes: 1.Statistical significance of differences between psychometrics at intake (0 month) and further assessments (Mixed ANOVA Main Time effect. Tukey test for post hoc comparisons):

*

p<0.01.

Main Group effects and interaction Time*Group effects for all variables are non-significant.

2. Statistical significance of differences between psychometrics at intake (0 month) and further assessments (Fridman Test and Wilcoxon Signed Ranks Test for post hoc comparisons):

+

p<0.05.

Mann–Whitney U test Between Group comparisons at all time points are non-significant.

3. The means are the means for all patients with data at a given time point.